东方海洋：全资子公司艾维可生物科技有限公司的高敏心肌肌钙蛋白I测定试剂盒获得医疗器械注册证

Core Viewpoint - The company, Dongfang Ocean, announced that its wholly-owned subsidiary, Aiveke Biotechnology Co., Ltd., has received a medical device registration certificate from the Shandong Provincial Drug Administration for its high-sensitivity cardiac troponin I (hs-cTnI) assay kit, which is approved for market launch [2] Group 1 - The hs-cTnI assay kit is designed for the quantitative detection of cardiac troponin I levels in human serum, plasma, and whole blood [2] - The product has been certified but has not yet been put into production, and its actual sales will depend on market expansion efforts and actual market demand [2] - The impact of Aiveke Biotechnology Co., Ltd. on the company's performance this year has been minimal, and the production and subsequent effects remain uncertain [2]